From 15-Nov-2019 a CBmed delegation was visiting the Samsung Medical Center in Seoul. Together with one of its funding agencies, the SFG and their CEO Mag. Ludwig, our delegation had joint discussions with Prof. Nam. Do-Hyun Nam, a leading expert in drug screening of cancer patients, gave insights into the facilities at Samsung Medical Center. Moreover, an exclusive background media coverage with Austrian press representatives took place. CBmed is looking forward to partner for drug screening in cancer, aiming to bring the newest cutting edge technologies to Austria.